2nd QUARTER 2023
Reporting
Evonik has published its quarterly report Q2 2023 on August 10, 2023.
You can access further information here.
- Q2 adj. EBITDA of €450 m slightly better than Q1 (€409 m)
- Recovery slower than expected in May and June;
persistently very weak demand across all end markets and continued customer destocking - Strict contingency measures with supportive effect; on track to achieve full effect of €250 m in second half of the year
- Revised adj. EBITDA outlook for FY 2023 of €1.6 to 1.8 bn no longer assumes any recovery in H2
- FCF broadly stable in H1 (yoy) despite significantly weaker adj. EBITDA;
FY target to develop cash conversion rate towards 40% confirmed
Reporting 2nd Quarter 2023
|
Document
|
Link / PDF
|
|
Analyst & Investor Factsheet
|
|
|
Presentation Conference Call
|
|
|
Detailed overview of key financial data (Evonik Financials) - as PDF |
|
|
Detailed overview of key financial data (Evonik Financials) - as Excel |
|
|
Half Year Financial Report 2023 |
|
|
Investor Relations News Q2 2023 |
|
|
Analysts' consensus* (Vara Research)
|
|
|
Webcast Conference Call Q2 2023 |
Preliminary Reporting 2nd Quarter 2023
|
Document |
Link / PDF |
|
Investor Relations News preliminary results Q2 2023 |
* The consensus is not controlled, changed or censored by Evonik Industries AG. Evonik Industries AG assumes no liability for the accuracy and completeness of these estimates and undertakes no obligation to update or revise such estimates and consensus data, even if they differ from Evonik Industries AG’s own forecasts or expectations. Evonik Industries AG is neither involved in the collection of the data, nor in the preparation of the consensus. This is done independently by Vara Research.